Endonovo Therapeutics Inc. (ENDV) Appoints Strategic Advisor to the CEO to Explore Growth Opportunities
The new strategic advisor, Dr. William Li, is a globally recognized medical professional One of Li’s primary specialties is the identification of unmet medical market needs that can be addressed through technological advances Endonovo is working to develop solutions for major therapeutic needs, especially in regard to pain management Its Electroceutical® SofPulse® is clinically proven to provide post-operative pain relief and speed up recovery On September 30, 2019, Endonovo Therapeutics Inc. (OTCQB: ENDV), a commercial-stage developer of innovative medical devices, announced the appointment of Dr. William Li as a strategic advisor to the CEO. The role of Li would be…